SRF CEO on Entrepreneurship and Longevity Conference Panel
On March 24th, SRF CEO Lisa Fabiny-Kiser will join a panel of innovators, investors, and executives to advance innovation and discuss longevity medicine with FDA regulatory experts.
Menu
SRF
EoY 2022-AmyloSENS
Week Seven of our 2022 End of Year Campaign features AmyloSENS (Removing Junk from Between Cells) – with a disease focus on Challenging Heart Disease. Also featuring videos from Life Noggin, AMA with Dr. Sudhir Paul and Michael Rae.
EoY 2022-OncoSENS
Week Two of our 2022 End of Year Campaign features MitoSENS (Preventing Damage from Mitochondrial Mutations) – with a disease focus on Challenging Sarcopenia. Also featuring videos from Life Noggin, AMA with Dr. Amit Sharma and Michael Rae.
EoY 2022RepleniSENS
Week Five of our 2022 End of Year Campaign features RepleniSENS (Replacing Lost Cells) – with a disease focus on Challenging Parkinson’s. Also featuring videos from Life Noggin, AMAs with Dr. Abdlehadi Rebbaa, Dr. Jean Héber & Michael Rae.
EoY 2022-GlycoSENS
Week Two of our 2022 End of Year Campaign features GlycoSENS (Repairing the Extracellular Matrix) – with a disease focus on Challenging Stroke. Also featuring videos from Life Noggin, AMA with Dr. Jonathan Clark and Michael Rae.
EoY 2022-LysoSENS
Week Two of our 2022 End of Year Campaign features LysoSENS (Clearing Waste Accumulations Out of Cells) – with a disease focus on Challenging Atherosclerosis. Also featuring videos from Life Noggin, AMA with Dr. Matthew O’Connor and Michael Rae.
EoY 2022-MitoSENS
Week Two of our 2022 End of Year Campaign features MitoSENS (Preventing Damage from Mitochondrial Mutations) – with a disease focus on Challenging Sarcopenia. Also featuring videos from Life Noggin, AMA with Dr. Amutha Boominathan and Michael Rae.
EoY 2022-ApoptoSENS
Week One of our 2022 End of Year Campaign features ApoptoSENS (Removing Dysfunctional Cells) – with a disease focus on Challenging Alzheimer’s. Also featuring videos from Life Noggin, AMA with Dr. Amit Sharma and Michael Rae.
Ending Aging Forum 2022
This virtual event is your opportunity to hear first-hand about the latest advances that our in-house researchers are making toward new rejuvenation biotechnologies, along with some of our young scientists-in-training and outside researchers whose research we fund.
Aging of the Immune System: Focus on Natural Killer Cells Phenotype and Functions
We are proud to announce the recent publication by the ApoptoSENS team led by Dr. Amit Sharma in the journal Cells describing the role and controversies involving the aging of Natural Killer (NK) cells and age-related NK cell dysfunction. This review focuses on recent advances and open questions in understanding the interplay between systemic inflammation, senescence burden, and NK cell dysfunction in the context of aging and potential therapies for age-related diseases.
